Homonymous Hemianopia in Childhood (NCT06115317) | Clinical Trial Compass
UnknownNot Applicable
Homonymous Hemianopia in Childhood
United Kingdom25 participantsStarted 2023-05-04
Plain-language summary
The study will consist of two connected components at a single centre. Phase 1 is observational, phenotyping children with Homonymous hemianopia (HH). Phase 2 is a pilot double blind cross over RCT in which segmental prisms are compared with sham prisms in glasses.
Who can participate
Age range5 Years – 17 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
✓. Clinical diagnosis of homonymous hemianopia
✓. Age 5 to 17
✓. Corrected visual acuity within normal limits for age,
✓. No evidence of eye pathology (pathology of the eye its self that causes additional visual impairment on top of the homonymous hemianopia) including no nystagmus
✓. No marked refractive error \> +/-5.00DS
✓. Complete homonymous hemianopia of more than 6 months - to avoid any natural recovery or adaptation (i.e. in stroke)
✓. Participation in phase 1 or copy of a detailed clinical assessment in the last 6 months from GOSH or a PIC site.
✓. No hemispatial visual neglect detected in phase one or a clinical assessment
Exclusion criteria
✕. Cannot establish definite clinical diagnosis of homonymous hemianopia
✕. Have participated in other studies undertaking intervention for homonymous hemianopia
✕. Reduced corrected visual acuity for age and/or high glasses prescription.
✕. Eye pathology (that causes additional visual impairment to the homonymous hemianopia) and/or nystagmus
✕. Homonymous hemianopia incomplete or less than 6 months old
What they're measuring
1
Is it possible to run a full randomised control trial of the use of segmental prisms in children with Homonymous Hemianopia?